Soroka University Medical Center
Clinical trials sponsored by Soroka University Medical Center, explained in plain language.
-
New pill combo aims to tame hepatitis d in small trial
Disease control CompletedThis completed Phase 3 trial tested a once-daily combination of two drugs, lonafarnib and ritonavir, in 10 adults with chronic hepatitis D. The goal was to see if the regimen is safe and can lower the amount of virus in the blood over 48 weeks of treatment and 24 weeks of follow-…
Phase: PHASE3 • Sponsor: Soroka University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Experimental COVID-19 drug shows promise in tiny trial
Disease control CompletedThis small pilot study tested whether adding pegylated interferon lambda to standard care helps hospitalized adults with mild-to-moderate COVID-19 recover faster. Nine participants were randomly assigned to receive the drug or standard care alone. The study measured how long the …
Phase: PHASE2 • Sponsor: Soroka University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Minutes, not days: new rapid test could speed up thyroid cancer detection
Diagnosis CompletedThis study tested a new rapid test that checks for thyroid cancer spread to neck lymph nodes in just minutes, instead of the usual days-long wait. Researchers studied 250 adults with suspected or known thyroid cancer, comparing the quick test to standard lab methods. The goal was…
Sponsor: Soroka University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Can an elliptical trainer help MS patients walk better?
Symptom relief CompletedThis study looked at how aerobic exercise on an elliptical trainer or a treadmill affects walking, balance, and stability in people with moderate multiple sclerosis. Thirty adults with MS completed the exercise programs. The goal was to see which machine might improve gait and wa…
Phase: NA • Sponsor: Soroka University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC